Plan for Microwave Thermal Field

Not Applicable

• Conditions: Hepatocellular Carcinoma; Ablation

• Registration Number: NCT05270642
• Lead Sponsor: Chinese PLA General Hospital

Brief Summary

Develop an intelligent system based on contrast-enhanced ultrasound and clinical information to help doctors automatically obtain ablation parameters (ablation needle number, ablation needle type, ablation time,ablation power) when preparing to use microwave ablation to treat hepatocellular carcinoma

Detailed Description

Not available

Study Timeline

• Study Start: 2021-10-01
• Status Verified: 2022-02
• Study First Submitted: 2022-02-27
• Study First Submitted QC: 2022-03-07
• Last Update Submitted: 2022-03-07
• Study First Posted: 2022-03-08
• Last Update Posted: 2022-03-08
• Primary Completion: 2022-12-30
• Study Completion: 2022-12-30

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 5

Inclusion Criteria

1. Biopsy or clinical diagnosis of HCC
2. Complete clinical information and preoperative CEUS
3. Curative treatment

Exclusion Criteria

1. Palliative care
2. Intolerance to ablation
3. Severe coagulation disorder

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
MRI within 3 days after ablation	MRI within 3 days after ablation	Postoperative MRI is used to determine whether the ablation zone completely covers the tumor and whether the size is appropriate
local tumor progression	6 months	Follow up to observe whether local tumor progression occurs within 6 months after ablation

Trial Locations

Locations (1)

Chinese PLA General Hospital; 🇨🇳 Beijing, Beijing, China